Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Immunic (IMUX – Research Report) on November 7 and set a price target ...

Multiple sclerosis (MS) is characterized by chronic inflammation ... Current treatment guidelines recommend starting disease-modifying therapies soon after disease onset. These treatments have ...

Multiple sclerosis is not merely a market—it’s a debilitating ... or is there a vested interest in maintaining a long-term demand for treatments that address symptoms rather than the root of the ...

A chronic and progressive neurological condition that affects millions across the world, multiple sclerosis (MS) can be a ...

In July, our management team was strengthened with the addition of Jason Tardio, as President and Chief Operating Officer, bringing with him a wealth of experience launching and commercializing ...

The quest to understand and slow disease progression in multiple sclerosis (MS) continued in 2024, with research revealing ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader ... authors allowed, because no licensed ...

New research has identified crucial links between dietary choices and the progression of multiple sclerosis (MS). The study explored how enzymes called ceramide synthase 5 and 6 are responsible for ...

The ketogenic diet could help manage multiple sclerosis (MS) by promoting the production of beneficial compounds in the gut.

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

Newly published research in the journal Glia has identified crucial links between dietary choices and the progression of multiple sclerosis (MS).